

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.52884031 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.52884031 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.18184815 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18184815 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.84750043 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.27330384 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.24387248 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.24387248 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.24387248 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.09233119 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.99098298 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 5.91552773 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 5.91552773 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.91552773 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.91552773 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.91552773 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 5.91552773 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.88362555 |
| 19 | urea cycle (GO:0000050) | 5.73685780 |
| 20 | urea metabolic process (GO:0019627) | 5.73685780 |
| 21 | glyoxylate metabolic process (GO:0046487) | 5.71454111 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61072461 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.59253529 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54817207 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.48883202 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 5.47249925 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.47126583 |
| 28 | negative regulation of cell killing (GO:0031342) | 5.47126583 |
| 29 | cysteine metabolic process (GO:0006534) | 5.45486174 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.41476620 |
| 31 | regulation of fibrinolysis (GO:0051917) | 5.38786647 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 5.37807295 |
| 33 | protein carboxylation (GO:0018214) | 5.37147982 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37147982 |
| 35 | response to peptidoglycan (GO:0032494) | 5.35430824 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.28596369 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 5.27242041 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 5.25405743 |
| 39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.20577670 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 5.18753856 |
| 41 | bile acid metabolic process (GO:0008206) | 5.11527424 |
| 42 | regulation of complement activation (GO:0030449) | 5.07300125 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 5.05167767 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 5.01186993 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.93365903 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.90899693 |
| 47 | detection of other organism (GO:0098543) | 4.89737204 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.86672579 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 4.86495984 |
| 50 | homocysteine metabolic process (GO:0050667) | 4.84508064 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.81024784 |
| 52 | reverse cholesterol transport (GO:0043691) | 4.80636995 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.78397353 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 4.74836900 |
| 55 | macromolecular complex remodeling (GO:0034367) | 4.74836900 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 4.74836900 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.71166439 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.66673652 |
| 59 | detection of external biotic stimulus (GO:0098581) | 4.65977733 |
| 60 | glycine metabolic process (GO:0006544) | 4.60314651 |
| 61 | lysine metabolic process (GO:0006553) | 4.59778028 |
| 62 | lysine catabolic process (GO:0006554) | 4.59778028 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.58697243 |
| 64 | triglyceride homeostasis (GO:0070328) | 4.57221587 |
| 65 | acylglycerol homeostasis (GO:0055090) | 4.57221587 |
| 66 | phospholipid efflux (GO:0033700) | 4.54828258 |
| 67 | negative regulation of sterol transport (GO:0032372) | 4.54677573 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 4.54677573 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.42701337 |
| 70 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.41702306 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 4.41131993 |
| 72 | cellular extravasation (GO:0045123) | 4.40845978 |
| 73 | detection of bacterium (GO:0016045) | 4.36980668 |
| 74 | cellular ketone body metabolic process (GO:0046950) | 4.35409772 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.35328029 |
| 76 | amine catabolic process (GO:0009310) | 4.35324966 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 4.35324966 |
| 78 | plasma lipoprotein particle clearance (GO:0034381) | 4.33373985 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 4.30260648 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 4.27648367 |
| 81 | cellular glucuronidation (GO:0052695) | 4.23181768 |
| 82 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19277771 |
| 83 | cholesterol efflux (GO:0033344) | 4.18280629 |
| 84 | * bile acid and bile salt transport (GO:0015721) | 4.16331047 |
| 85 | glutamate metabolic process (GO:0006536) | 4.15189820 |
| 86 | detection of biotic stimulus (GO:0009595) | 4.15006324 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.13881137 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 4.12734604 |
| 89 | ethanol oxidation (GO:0006069) | 4.10434327 |
| 90 | neutrophil activation (GO:0042119) | 4.09299303 |
| 91 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.08291008 |
| 92 | fibrinolysis (GO:0042730) | 4.04919354 |
| 93 | microglial cell activation (GO:0001774) | 4.04485850 |
| 94 | arginine metabolic process (GO:0006525) | 4.03675112 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 4.02727800 |
| 96 | leukocyte aggregation (GO:0070486) | 4.02487387 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 4.01609855 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.00007243 |
| 99 | response to host immune response (GO:0052572) | 4.00007243 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 3.97574613 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.97224692 |
| 102 | plasma lipoprotein particle assembly (GO:0034377) | 3.96363733 |
| 103 | macrophage activation (GO:0042116) | 3.95144159 |
| 104 | aldehyde catabolic process (GO:0046185) | 3.93402648 |
| 105 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.93221232 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.91822866 |
| 107 | neutrophil mediated immunity (GO:0002446) | 3.90503711 |
| 108 | drug catabolic process (GO:0042737) | 3.89598411 |
| 109 | granulocyte activation (GO:0036230) | 3.87249502 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86883647 |
| 111 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.86767846 |
| 112 | respiratory burst (GO:0045730) | 3.85122935 |
| 113 | cofactor catabolic process (GO:0051187) | 3.85000969 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.84420214 |
| 115 | complement activation (GO:0006956) | 3.81920705 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.81907483 |
| 117 | protein activation cascade (GO:0072376) | 3.80661777 |
| 118 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.79547283 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77971220 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77971220 |
| 121 | ketone body metabolic process (GO:1902224) | 3.76048594 |
| 122 | carboxylic acid catabolic process (GO:0046395) | 3.74693473 |
| 123 | organic acid catabolic process (GO:0016054) | 3.74693473 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74386115 |
| 125 | cholesterol homeostasis (GO:0042632) | 3.73027322 |
| 126 | glucuronate metabolic process (GO:0019585) | 3.72629528 |
| 127 | uronic acid metabolic process (GO:0006063) | 3.72629528 |
| 128 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72570417 |
| 129 | immunoglobulin mediated immune response (GO:0016064) | 3.72268050 |
| 130 | cytolysis (GO:0019835) | 3.70559449 |
| 131 | phospholipid homeostasis (GO:0055091) | 3.70004046 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 3.69702252 |
| 133 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.68810346 |
| 134 | negative regulation of lipase activity (GO:0060192) | 3.67947231 |
| 135 | sterol homeostasis (GO:0055092) | 3.66662543 |
| 136 | response to host (GO:0075136) | 3.64506429 |
| 137 | response to host defenses (GO:0052200) | 3.64506429 |
| 138 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.64506429 |
| 139 | NAD biosynthetic process (GO:0009435) | 3.63737924 |
| 140 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.62446915 |
| 141 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.62446915 |
| 142 | acetyl-CoA metabolic process (GO:0006084) | 3.61919165 |
| 143 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.61913170 |
| 144 | plasma lipoprotein particle organization (GO:0071827) | 3.60504903 |
| 145 | type I interferon signaling pathway (GO:0060337) | 3.59581928 |
| 146 | cellular response to type I interferon (GO:0071357) | 3.59581928 |
| 147 | germinal center formation (GO:0002467) | 3.59035648 |
| 148 | regulation of cholesterol homeostasis (GO:2000188) | 3.58290623 |
| 149 | short-chain fatty acid metabolic process (GO:0046459) | 3.57215612 |
| 150 | response to type I interferon (GO:0034340) | 3.55877218 |
| 151 | myeloid cell activation involved in immune response (GO:0002275) | 3.52726643 |
| 152 | response to interleukin-15 (GO:0070672) | 3.47120660 |
| 153 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.37265856 |
| 154 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.36926120 |
| 155 | defense response to protozoan (GO:0042832) | 3.35318925 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 3.34570142 |
| 157 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33869815 |
| 158 | positive regulation of interferon-alpha production (GO:0032727) | 3.33051396 |
| 159 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.32877853 |
| 160 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.31646624 |
| 161 | myeloid leukocyte mediated immunity (GO:0002444) | 3.31305656 |
| 162 | regulation of interferon-alpha production (GO:0032647) | 3.30960981 |
| 163 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29293153 |
| 164 | T-helper 1 type immune response (GO:0042088) | 3.27519584 |
| 165 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27086312 |
| 166 | response to muramyl dipeptide (GO:0032495) | 3.25096130 |
| 167 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.23924250 |
| 168 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.20171299 |
| 169 | cellular response to interleukin-15 (GO:0071350) | 3.12965143 |
| 170 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12682066 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11924613 |
| 172 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11388763 |
| 173 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10308240 |
| 174 | positive regulation of mast cell activation (GO:0033005) | 3.08298191 |
| 175 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.07657928 |
| 176 | regulation of tolerance induction (GO:0002643) | 3.05234711 |
| 177 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.04392865 |
| 178 | response to protozoan (GO:0001562) | 3.00544250 |
| 179 | regulation of mast cell activation (GO:0033003) | 2.98875215 |
| 180 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96718060 |
| 181 | neutrophil chemotaxis (GO:0030593) | 2.96378255 |
| 182 | regulation of leukocyte degranulation (GO:0043300) | 2.91435771 |
| 183 | regulation of T cell tolerance induction (GO:0002664) | 2.91155463 |
| 184 | B cell mediated immunity (GO:0019724) | 2.90864019 |
| 185 | dendritic cell chemotaxis (GO:0002407) | 2.89836409 |
| 186 | negative regulation of interleukin-6 production (GO:0032715) | 2.89463634 |
| 187 | myeloid leukocyte activation (GO:0002274) | 2.89098589 |
| 188 | neutrophil migration (GO:1990266) | 2.88523499 |
| 189 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.86619035 |
| 190 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.86114111 |
| 191 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.85300631 |
| 192 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.84981118 |
| 193 | positive regulation of type 2 immune response (GO:0002830) | 2.84355934 |
| 194 | dendritic cell migration (GO:0036336) | 2.83646940 |
| 195 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82529969 |
| 196 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.82325420 |
| 197 | positive regulation of interferon-beta production (GO:0032728) | 2.79952614 |
| 198 | leukocyte degranulation (GO:0043299) | 2.79090441 |
| 199 | negative regulation of innate immune response (GO:0045824) | 2.77996594 |
| 200 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.77066893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37479204 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20907156 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.14534474 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43254679 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28052670 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.27628258 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.15559500 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80557192 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.72334813 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.19038533 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83665176 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67179251 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58627678 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.52022506 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50082466 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.47964493 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.98474011 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95053686 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79182529 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.54079596 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49342572 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.47253380 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.30413507 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23744331 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23118819 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18775342 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.14870156 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.08420193 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04251128 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.01982138 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01044493 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00311380 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9804636 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.99211591 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96637050 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94770662 |
| 37 | * MYB_26560356_Chip-Seq_TH2_Human | 1.94701492 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94686590 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92000288 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90170466 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82208899 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.68336388 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67297887 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65987267 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63393793 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62148148 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61096307 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60922922 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60537074 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54739745 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54724840 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54586937 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49485119 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48562424 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48260009 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46200567 |
| 57 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41828634 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41112178 |
| 59 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38328178 |
| 60 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38178710 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.35595934 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35321535 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.33446485 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33146591 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32408996 |
| 66 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32167320 |
| 67 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.27547865 |
| 68 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26999038 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26951613 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25132806 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25115570 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24832939 |
| 73 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23690062 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20991008 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19930941 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18958370 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18018359 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16680223 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14737774 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14508687 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13476251 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10619587 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10422244 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07458648 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05269153 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03754487 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02977778 |
| 88 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02164651 |
| 89 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.01291533 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00305060 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99716735 |
| 92 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95898683 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94782975 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91796949 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90363334 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90317430 |
| 97 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90094534 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87297404 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86446232 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85204206 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82900576 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82312437 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81687395 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81532651 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.80817887 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80619363 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.80299266 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79584875 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78855649 |
| 110 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76535308 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73572943 |
| 112 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71560399 |
| 113 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.71314903 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71202466 |
| 115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70919908 |
| 116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69885608 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.67820098 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.66262933 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65722606 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65121119 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64907124 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62592196 |
| 123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61088629 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60956161 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59243385 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57070896 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56670064 |
| 128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.55548794 |
| 129 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.53186005 |
| 130 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.52793317 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52184269 |
| 132 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51227612 |
| 133 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50868674 |
| 134 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50322875 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50203517 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49605591 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.49550840 |
| 138 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49410718 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.48105088 |
| 140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.48105088 |
| 141 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47542126 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46168548 |
| 143 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46019978 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45538403 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45213864 |
| 146 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44831919 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44335597 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.43567428 |
| 149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43464826 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43365800 |
| 151 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.42099740 |
| 152 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.40334001 |
| 153 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.40168202 |
| 154 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.39630934 |
| 155 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39442420 |
| 156 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38529199 |
| 157 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.38357026 |
| 158 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.38101306 |
| 159 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.37689788 |
| 160 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.37323612 |
| 161 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.37180898 |
| 162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36821541 |
| 163 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36724607 |
| 164 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.36712135 |
| 165 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36566852 |
| 166 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35980579 |
| 167 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.35917217 |
| 168 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.35756700 |
| 169 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35279197 |
| 170 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.35162156 |
| 171 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.34916767 |
| 172 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.34015881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27537552 |
| 2 | MP0005360_urolithiasis | 7.37972568 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43746761 |
| 4 | MP0005365_abnormal_bile_salt | 6.16984511 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15645400 |
| 6 | MP0003303_peritoneal_inflammation | 4.69961705 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.21088563 |
| 8 | MP0003252_abnormal_bile_duct | 3.87920294 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.54221871 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.42294624 |
| 11 | MP0009840_abnormal_foam_cell | 3.41354498 |
| 12 | MP0002419_abnormal_innate_immunity | 3.13322254 |
| 13 | MP0005083_abnormal_biliary_tract | 2.95589173 |
| 14 | MP0003195_calcinosis | 2.77441941 |
| 15 | * MP0005025_abnormal_response_to | 2.76819782 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.76783600 |
| 17 | MP0005332_abnormal_amino_acid | 2.72900417 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.64582740 |
| 19 | MP0005671_abnormal_response_to | 2.64415397 |
| 20 | MP0001790_abnormal_immune_system | 2.61198401 |
| 21 | MP0005387_immune_system_phenotype | 2.61198401 |
| 22 | MP0001800_abnormal_humoral_immune | 2.60239954 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.53504647 |
| 24 | MP0002723_abnormal_immune_serum | 2.44779604 |
| 25 | MP0000685_abnormal_immune_system | 2.43037281 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.39883380 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.36734087 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.35899096 |
| 29 | MP0001533_abnormal_skeleton_physiology | 2.23158561 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.22171368 |
| 31 | MP0001819_abnormal_immune_cell | 2.20862417 |
| 32 | MP0000609_abnormal_liver_physiology | 2.20204862 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 2.14836279 |
| 34 | * MP0002118_abnormal_lipid_homeostasis | 2.05315578 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.97073089 |
| 36 | MP0003868_abnormal_feces_composition | 1.91410187 |
| 37 | MP0008260_abnormal_autophagy | 1.90919464 |
| 38 | MP0009278_abnormal_bone_marrow | 1.89794076 |
| 39 | MP0002405_respiratory_system_inflammati | 1.87858369 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.87130439 |
| 41 | MP0001764_abnormal_homeostasis | 1.78807012 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.72750679 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.72183298 |
| 44 | MP0004510_myositis | 1.71360789 |
| 45 | MP0009697_abnormal_copulation | 1.61931686 |
| 46 | MP0005451_abnormal_body_composition | 1.61344301 |
| 47 | MP0000716_abnormal_immune_system | 1.61283317 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.58342039 |
| 49 | MP0003828_pulmonary_edema | 1.57513268 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55253706 |
| 51 | MP0002398_abnormal_bone_marrow | 1.52909565 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.44487523 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.44487523 |
| 54 | MP0003011_delayed_dark_adaptation | 1.44046690 |
| 55 | MP0000858_altered_metastatic_potential | 1.42174946 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.40840958 |
| 57 | MP0003186_abnormal_redox_activity | 1.37657687 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.36884773 |
| 59 | MP0005164_abnormal_response_to | 1.36280934 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.34438198 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.28330931 |
| 62 | MP0002722_abnormal_immune_system | 1.27096232 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.26840410 |
| 64 | MP0008004_abnormal_stomach_pH | 1.26145943 |
| 65 | MP0002429_abnormal_blood_cell | 1.23115532 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.22906553 |
| 67 | MP0000598_abnormal_liver_morphology | 1.22289637 |
| 68 | MP0000343_altered_response_to | 1.20916255 |
| 69 | MP0005310_abnormal_salivary_gland | 1.20419685 |
| 70 | MP0005647_abnormal_sex_gland | 1.17621417 |
| 71 | MP0009764_decreased_sensitivity_to | 1.17340415 |
| 72 | MP0003448_altered_tumor_morphology | 1.15211378 |
| 73 | MP0003866_abnormal_defecation | 1.13320376 |
| 74 | MP0002332_abnormal_exercise_endurance | 1.13304790 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.09472736 |
| 76 | MP0009763_increased_sensitivity_to | 1.07805701 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.06493863 |
| 78 | MP0000604_amyloidosis | 1.05159891 |
| 79 | MP0001851_eye_inflammation | 1.03907056 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.01775377 |
| 81 | * MP0003656_abnormal_erythrocyte_physiolo | 1.00969477 |
| 82 | MP0008469_abnormal_protein_level | 0.99262588 |
| 83 | MP0002254_reproductive_system_inflammat | 0.99147162 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.96046147 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.94317166 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.88921700 |
| 87 | * MP0009642_abnormal_blood_homeostasis | 0.87347260 |
| 88 | MP0005408_hypopigmentation | 0.86730204 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.86191847 |
| 90 | MP0005390_skeleton_phenotype | 0.85456910 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.83601246 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82366825 |
| 93 | MP0005670_abnormal_white_adipose | 0.81612576 |
| 94 | MP0005376_homeostasis/metabolism_phenot | 0.80729535 |
| 95 | MP0001663_abnormal_digestive_system | 0.77493870 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.75550224 |
| 97 | MP0003045_fibrosis | 0.74023218 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.72979553 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.71832884 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.70960380 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.70338514 |
| 102 | MP0001661_extended_life_span | 0.70091233 |
| 103 | MP0002971_abnormal_brown_adipose | 0.69635316 |
| 104 | * MP0002078_abnormal_glucose_homeostasis | 0.69586662 |
| 105 | MP0005334_abnormal_fat_pad | 0.68734618 |
| 106 | MP0003718_maternal_effect | 0.68210162 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.68029411 |
| 108 | MP0006054_spinal_hemorrhage | 0.66925563 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.66423787 |
| 110 | MP0004130_abnormal_muscle_cell | 0.66417841 |
| 111 | MP0002006_tumorigenesis | 0.65518083 |
| 112 | MP0003724_increased_susceptibility_to | 0.65425246 |
| 113 | MP0005535_abnormal_body_temperature | 0.65292073 |
| 114 | MP0002166_altered_tumor_susceptibility | 0.64047886 |
| 115 | MP0003690_abnormal_glial_cell | 0.63737428 |
| 116 | MP0005266_abnormal_metabolism | 0.63056460 |
| 117 | MP0004808_abnormal_hematopoietic_stem | 0.61642477 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.61173972 |
| 119 | MP0003091_abnormal_cell_migration | 0.60934174 |
| 120 | MP0003436_decreased_susceptibility_to | 0.60585362 |
| 121 | MP0000920_abnormal_myelination | 0.59997963 |
| 122 | MP0001756_abnormal_urination | 0.59354501 |
| 123 | MP0003329_amyloid_beta_deposits | 0.56264513 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.55377548 |
| 125 | MP0005395_other_phenotype | 0.54934080 |
| 126 | MP0009053_abnormal_anal_canal | 0.53674460 |
| 127 | MP0005448_abnormal_energy_balance | 0.50870828 |
| 128 | MP0004381_abnormal_hair_follicle | 0.48834688 |
| 129 | MP0001853_heart_inflammation | 0.48681340 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.48634947 |
| 131 | MP0008873_increased_physiological_sensi | 0.48110245 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.47599703 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.47151440 |
| 134 | MP0002928_abnormal_bile_duct | 0.43138221 |
| 135 | MP0008874_decreased_physiological_sensi | 0.43111196 |
| 136 | MP0006082_CNS_inflammation | 0.41527813 |
| 137 | MP0003075_altered_response_to | 0.41424456 |
| 138 | MP0002132_abnormal_respiratory_system | 0.41169938 |
| 139 | MP0005166_decreased_susceptibility_to | 0.39779511 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.38676784 |
| 141 | MP0008872_abnormal_physiological_respon | 0.38145415 |
| 142 | MP0003953_abnormal_hormone_level | 0.37558832 |
| 143 | MP0002796_impaired_skin_barrier | 0.36239602 |
| 144 | MP0009115_abnormal_fat_cell | 0.35956663 |
| 145 | MP0009672_abnormal_birth_weight | 0.34636331 |
| 146 | MP0002822_catalepsy | 0.34432915 |
| 147 | MP0000579_abnormal_nail_morphology | 0.34119737 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.33334745 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.33225383 |
| 150 | MP0000249_abnormal_blood_vessel | 0.33037128 |
| 151 | MP0001243_abnormal_dermal_layer | 0.32331765 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.31956905 |
| 153 | MP0009785_altered_susceptibility_to | 0.30587015 |
| 154 | MP0002970_abnormal_white_adipose | 0.30472043 |
| 155 | MP0004883_abnormal_blood_vessel | 0.29957756 |
| 156 | MP0001881_abnormal_mammary_gland | 0.29673452 |
| 157 | MP0000230_abnormal_systemic_arterial | 0.28590426 |
| 158 | MP0002837_dystrophic_cardiac_calcinosis | 0.28076258 |
| 159 | MP0004947_skin_inflammation | 0.26559428 |
| 160 | MP0002168_other_aberrant_phenotype | 0.26486972 |
| 161 | MP0005075_abnormal_melanosome_morpholog | 0.26034311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.33641414 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.33115848 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.28689436 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65126095 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.61679104 |
| 6 | Eczematoid dermatitis (HP:0000976) | 6.47535664 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.38330490 |
| 8 | Orchitis (HP:0100796) | 6.33809640 |
| 9 | Xanthomatosis (HP:0000991) | 6.21700511 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 6.15008629 |
| 11 | Optic neuritis (HP:0100653) | 6.15008629 |
| 12 | Myositis (HP:0100614) | 6.12393986 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 5.93357428 |
| 14 | Recurrent abscess formation (HP:0002722) | 5.88408756 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 5.64063820 |
| 16 | Abnormality of macrophages (HP:0004311) | 5.46190501 |
| 17 | Complement deficiency (HP:0004431) | 5.43750791 |
| 18 | Stomatitis (HP:0010280) | 5.05819212 |
| 19 | Joint hemorrhage (HP:0005261) | 4.82418824 |
| 20 | Hypolipoproteinemia (HP:0010981) | 4.76768486 |
| 21 | Hyperammonemia (HP:0001987) | 4.61508281 |
| 22 | Hyperglycinemia (HP:0002154) | 4.56270882 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 4.47780719 |
| 24 | Epidermoid cyst (HP:0200040) | 4.46303951 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44416447 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.40440132 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.38074962 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 4.32522197 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 4.29806504 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26130215 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 4.15922065 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 4.14798377 |
| 33 | Ketosis (HP:0001946) | 4.14626688 |
| 34 | Keratoconjunctivitis (HP:0001096) | 4.12271349 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11510677 |
| 36 | Fat malabsorption (HP:0002630) | 4.10435251 |
| 37 | Hyperglycinuria (HP:0003108) | 4.02412681 |
| 38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01245384 |
| 39 | Abnormality of complement system (HP:0005339) | 3.99340723 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.98034294 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.98034294 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.94694761 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78294915 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 3.76374144 |
| 45 | Obstructive lung disease (HP:0006536) | 3.76374144 |
| 46 | Hypoglycemic coma (HP:0001325) | 3.71355867 |
| 47 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70760707 |
| 48 | Recurrent skin infections (HP:0001581) | 3.70623661 |
| 49 | Recurrent fungal infections (HP:0002841) | 3.70426797 |
| 50 | Hypercholesterolemia (HP:0003124) | 3.63944214 |
| 51 | Meningitis (HP:0001287) | 3.62426137 |
| 52 | Encephalitis (HP:0002383) | 3.55537484 |
| 53 | Vasculitis (HP:0002633) | 3.54913729 |
| 54 | Gingivitis (HP:0000230) | 3.51329186 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41775275 |
| 56 | Hyperbilirubinemia (HP:0002904) | 3.37633438 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37602938 |
| 58 | Urticaria (HP:0001025) | 3.33566248 |
| 59 | Spontaneous hematomas (HP:0007420) | 3.31820093 |
| 60 | Peritonitis (HP:0002586) | 3.23398058 |
| 61 | Arterial thrombosis (HP:0004420) | 3.23352790 |
| 62 | Gangrene (HP:0100758) | 3.21964773 |
| 63 | Hemoptysis (HP:0002105) | 3.21128786 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 3.19747669 |
| 65 | Steatorrhea (HP:0002570) | 3.14639531 |
| 66 | Spontaneous abortion (HP:0005268) | 3.14246253 |
| 67 | Anorexia (HP:0002039) | 3.13075889 |
| 68 | Episodic fever (HP:0001954) | 3.13042341 |
| 69 | Pulmonary infiltrates (HP:0002113) | 3.11336477 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.10461604 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10268432 |
| 72 | Increased IgE level (HP:0003212) | 3.08360815 |
| 73 | T lymphocytopenia (HP:0005403) | 3.07783741 |
| 74 | Delayed CNS myelination (HP:0002188) | 3.04959220 |
| 75 | Myocardial infarction (HP:0001658) | 2.98946362 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.96098886 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.94568854 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.93981001 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.93981001 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.93981001 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.91801484 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90143688 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90143688 |
| 84 | Chest pain (HP:0100749) | 2.88857337 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.84987217 |
| 86 | Ketoacidosis (HP:0001993) | 2.80397873 |
| 87 | Metabolic acidosis (HP:0001942) | 2.73327493 |
| 88 | Leukocytosis (HP:0001974) | 2.72130625 |
| 89 | Acanthocytosis (HP:0001927) | 2.70703310 |
| 90 | Cellulitis (HP:0100658) | 2.69685582 |
| 91 | Skin nodule (HP:0200036) | 2.68599886 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.68055268 |
| 93 | Lethargy (HP:0001254) | 2.63283390 |
| 94 | Hypochromic anemia (HP:0001931) | 2.63198058 |
| 95 | Increased IgM level (HP:0003496) | 2.63179803 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61839491 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 2.61839491 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60327546 |
| 99 | Prolonged bleeding time (HP:0003010) | 2.60301380 |
| 100 | Vascular calcification (HP:0004934) | 2.54759153 |
| 101 | Abnormality of the pleura (HP:0002103) | 2.51504738 |
| 102 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.50277395 |
| 103 | Glomerulonephritis (HP:0000099) | 2.49812655 |
| 104 | Epistaxis (HP:0000421) | 2.48914471 |
| 105 | Gout (HP:0001997) | 2.48389295 |
| 106 | Spastic diplegia (HP:0001264) | 2.46280089 |
| 107 | Gingival bleeding (HP:0000225) | 2.41069301 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.40865418 |
| 109 | Loss of speech (HP:0002371) | 2.37949741 |
| 110 | Recurrent viral infections (HP:0004429) | 2.37210504 |
| 111 | Cholelithiasis (HP:0001081) | 2.35579139 |
| 112 | Irritability (HP:0000737) | 2.35289747 |
| 113 | Cerebral edema (HP:0002181) | 2.34114372 |
| 114 | Mitral stenosis (HP:0001718) | 2.31824527 |
| 115 | Abnormality of the endocardium (HP:0004306) | 2.31543800 |
| 116 | Abnormality of the peritoneum (HP:0002585) | 2.31308317 |
| 117 | Cholecystitis (HP:0001082) | 2.31062195 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 2.31062195 |
| 119 | Hypoglycemic seizures (HP:0002173) | 2.29294612 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 2.28936222 |
| 121 | Menorrhagia (HP:0000132) | 2.28806413 |
| 122 | Neonatal onset (HP:0003623) | 2.27031153 |
| 123 | Increased serum ferritin (HP:0003281) | 2.25611666 |
| 124 | Amyloidosis (HP:0011034) | 2.24305166 |
| 125 | Cardiovascular calcification (HP:0011915) | 2.23396189 |
| 126 | Brushfield spots (HP:0001088) | 2.23025689 |
| 127 | Osteomyelitis (HP:0002754) | 2.22422383 |
| 128 | Acne (HP:0001061) | 2.22398572 |
| 129 | Glomerulopathy (HP:0100820) | 2.21927323 |
| 130 | Esophageal varix (HP:0002040) | 2.20916462 |
| 131 | Sepsis (HP:0100806) | 2.19564008 |
| 132 | Purpura (HP:0000979) | 2.19492054 |
| 133 | Abnormality of T cells (HP:0002843) | 2.19465368 |
| 134 | Poikilocytosis (HP:0004447) | 2.18987455 |
| 135 | Keratitis (HP:0000491) | 2.18225148 |
| 136 | Inflammation of the large intestine (HP:0002037) | 2.17764666 |
| 137 | Malnutrition (HP:0004395) | 2.17034095 |
| 138 | Autoimmune thrombocytopenia (HP:0001973) | 2.16962005 |
| 139 | Thrombophlebitis (HP:0004418) | 2.15701398 |
| 140 | Vertigo (HP:0002321) | 2.15693956 |
| 141 | Hypergammaglobulinemia (HP:0010702) | 2.14442634 |
| 142 | Disinhibition (HP:0000734) | 2.14262721 |
| 143 | Pancreatitis (HP:0001733) | 2.12710999 |
| 144 | Petechiae (HP:0000967) | 2.11769924 |
| 145 | Abnormality of the pericardium (HP:0001697) | 2.11513016 |
| 146 | Sensorimotor neuropathy (HP:0007141) | 2.10436006 |
| 147 | Granulocytopenia (HP:0001913) | 2.09156203 |
| 148 | Polyneuropathy (HP:0001271) | 2.08107201 |
| 149 | Joint swelling (HP:0001386) | 2.06668524 |
| 150 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06240611 |
| 151 | Gastrointestinal inflammation (HP:0004386) | 2.05569121 |
| 152 | Generalized aminoaciduria (HP:0002909) | 2.03260212 |
| 153 | Opisthotonus (HP:0002179) | 2.02023425 |
| 154 | Vomiting (HP:0002013) | 2.00897548 |
| 155 | Abnormality of iron homeostasis (HP:0011031) | 2.00130762 |
| 156 | Microcytic anemia (HP:0001935) | 1.98382495 |
| 157 | Late onset (HP:0003584) | 1.98343936 |
| 158 | Hemorrhage of the eye (HP:0011885) | 1.96899712 |
| 159 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96174965 |
| 160 | Premature loss of primary teeth (HP:0006323) | 1.96112965 |
| 161 | Abnormality of the gallbladder (HP:0005264) | 1.95400677 |
| 162 | Enlarged kidneys (HP:0000105) | 1.94658302 |
| 163 | Pustule (HP:0200039) | 1.94377817 |
| 164 | Interstitial pulmonary disease (HP:0006530) | 1.93634447 |
| 165 | Slow saccadic eye movements (HP:0000514) | 1.93085506 |
| 166 | Hepatosplenomegaly (HP:0001433) | 1.91785122 |
| 167 | Eosinophilia (HP:0001880) | 1.91047483 |
| 168 | Renal cortical cysts (HP:0000803) | 1.88572371 |
| 169 | Elevated hepatic transaminases (HP:0002910) | 1.87421701 |
| 170 | Acute hepatic failure (HP:0006554) | 1.86390588 |
| 171 | Recurrent pneumonia (HP:0006532) | 1.85751717 |
| 172 | Abnormal cartilage morphology (HP:0002763) | 1.85447896 |
| 173 | Subacute progressive viral hepatitis (HP:0006572) | 1.83916727 |
| 174 | Autoimmune hemolytic anemia (HP:0001890) | 1.83592132 |
| 175 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83420997 |
| 176 | Rickets (HP:0002748) | 1.82901503 |
| 177 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80910651 |
| 178 | Skin ulcer (HP:0200042) | 1.79223312 |
| 179 | Arthralgia (HP:0002829) | 1.79156473 |
| 180 | Splenomegaly (HP:0001744) | 1.78891566 |
| 181 | Dysostosis multiplex (HP:0000943) | 1.78583027 |
| 182 | Nephritis (HP:0000123) | 1.75336946 |
| 183 | Reticulocytosis (HP:0001923) | 1.74781883 |
| 184 | Hydroxyprolinuria (HP:0003080) | 1.73431438 |
| 185 | Abnormality of proline metabolism (HP:0010907) | 1.73431438 |
| 186 | Hyperglycemia (HP:0003074) | 1.72257093 |
| 187 | Hypophosphatemic rickets (HP:0004912) | 1.71701635 |
| 188 | Hypertriglyceridemia (HP:0002155) | 1.71578843 |
| 189 | Pulmonary embolism (HP:0002204) | 1.71351796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.17835834 |
| 2 | RIPK4 | 4.60603100 |
| 3 | FGFR4 | 4.54696533 |
| 4 | SIK1 | 4.24156369 |
| 5 | ERN1 | 4.18803385 |
| 6 | IRAK4 | 3.53850265 |
| 7 | TAOK3 | 3.37034138 |
| 8 | ERBB4 | 2.85730015 |
| 9 | INSRR | 2.73851052 |
| 10 | MAP2K4 | 2.21414072 |
| 11 | PKN2 | 2.12613313 |
| 12 | MST1R | 2.09265752 |
| 13 | TXK | 2.06623760 |
| 14 | MAPK11 | 2.04817444 |
| 15 | FLT3 | 2.04119802 |
| 16 | FGR | 2.02815027 |
| 17 | TYK2 | 2.00230172 |
| 18 | TAOK1 | 1.98244523 |
| 19 | FES | 1.92316542 |
| 20 | PRPF4B | 1.85662774 |
| 21 | PIK3CG | 1.76840524 |
| 22 | MATK | 1.71447287 |
| 23 | TRIB3 | 1.69864515 |
| 24 | TNK2 | 1.69200864 |
| 25 | LATS1 | 1.65542638 |
| 26 | ABL2 | 1.61213756 |
| 27 | HCK | 1.57149264 |
| 28 | PINK1 | 1.56333759 |
| 29 | NEK9 | 1.54171621 |
| 30 | IRAK2 | 1.50613125 |
| 31 | KDR | 1.44898671 |
| 32 | MAP3K1 | 1.42493704 |
| 33 | IRAK3 | 1.40909717 |
| 34 | SYK | 1.38268041 |
| 35 | BMPR2 | 1.37029375 |
| 36 | TBK1 | 1.35264984 |
| 37 | KSR2 | 1.34819913 |
| 38 | JAK2 | 1.33591124 |
| 39 | LYN | 1.31730665 |
| 40 | MAP2K3 | 1.29029027 |
| 41 | PTK6 | 1.26847032 |
| 42 | YES1 | 1.22740768 |
| 43 | SIK3 | 1.18151214 |
| 44 | DAPK2 | 1.17521734 |
| 45 | PRKAA2 | 1.16390238 |
| 46 | FRK | 1.15867400 |
| 47 | MAP3K14 | 1.09253789 |
| 48 | MAPK4 | 1.06672649 |
| 49 | GRK7 | 1.05088185 |
| 50 | TIE1 | 1.04847783 |
| 51 | JAK1 | 1.03533397 |
| 52 | MAP3K7 | 1.02224073 |
| 53 | GRK6 | 1.01339009 |
| 54 | ERBB2 | 0.99752637 |
| 55 | FGFR2 | 0.99368897 |
| 56 | LCK | 0.99350125 |
| 57 | MAP3K2 | 0.95954634 |
| 58 | MARK3 | 0.95893949 |
| 59 | MAP3K3 | 0.95661421 |
| 60 | STK38L | 0.92611619 |
| 61 | MAP3K11 | 0.89325397 |
| 62 | CDK6 | 0.86032540 |
| 63 | MARK2 | 0.83911801 |
| 64 | CSF1R | 0.78178076 |
| 65 | CDC42BPA | 0.77797939 |
| 66 | MAPK12 | 0.76643310 |
| 67 | EPHA3 | 0.74497753 |
| 68 | STK10 | 0.73968490 |
| 69 | MAP3K10 | 0.73375233 |
| 70 | ITK | 0.71922198 |
| 71 | EPHB1 | 0.71733162 |
| 72 | PRKACG | 0.71651039 |
| 73 | IKBKE | 0.71133930 |
| 74 | CAMK1D | 0.70000820 |
| 75 | MAP2K6 | 0.68878606 |
| 76 | PRKAA1 | 0.68119333 |
| 77 | CSK | 0.65942180 |
| 78 | CDK4 | 0.65389030 |
| 79 | TGFBR2 | 0.65105558 |
| 80 | TESK2 | 0.64854920 |
| 81 | MAP3K5 | 0.60113582 |
| 82 | MET | 0.59519165 |
| 83 | FYN | 0.59511405 |
| 84 | DYRK1B | 0.59328094 |
| 85 | PRKD2 | 0.59031069 |
| 86 | CAMK2G | 0.58245384 |
| 87 | MAPK15 | 0.58113370 |
| 88 | KIT | 0.57565073 |
| 89 | MAP4K1 | 0.57529278 |
| 90 | LRRK2 | 0.57035196 |
| 91 | SIK2 | 0.56303283 |
| 92 | PDK3 | 0.56291023 |
| 93 | PDK4 | 0.56291023 |
| 94 | GSK3A | 0.56042664 |
| 95 | GRK1 | 0.53706381 |
| 96 | KSR1 | 0.53267566 |
| 97 | CHUK | 0.52638361 |
| 98 | TAOK2 | 0.52471313 |
| 99 | RAF1 | 0.51728602 |
| 100 | TEC | 0.51613967 |
| 101 | CSNK1G1 | 0.51001201 |
| 102 | MOS | 0.50768201 |
| 103 | STK3 | 0.50252029 |
| 104 | SGK3 | 0.50121601 |
| 105 | MAP3K6 | 0.50019211 |
| 106 | FGFR3 | 0.49646530 |
| 107 | DYRK3 | 0.48563109 |
| 108 | MAPK7 | 0.48558313 |
| 109 | PDPK1 | 0.46717788 |
| 110 | STK11 | 0.46420909 |
| 111 | PIM1 | 0.44829882 |
| 112 | NLK | 0.43788475 |
| 113 | CDK19 | 0.43504189 |
| 114 | * PRKCZ | 0.43140549 |
| 115 | AKT3 | 0.42821923 |
| 116 | PTK2B | 0.41797761 |
| 117 | PRKCQ | 0.41568503 |
| 118 | HIPK2 | 0.41266410 |
| 119 | IGF1R | 0.40636832 |
| 120 | RIPK1 | 0.39037744 |
| 121 | WNK1 | 0.38267849 |
| 122 | STK16 | 0.38003386 |
| 123 | EIF2AK1 | 0.36618190 |
| 124 | RPS6KL1 | 0.35817045 |
| 125 | RPS6KC1 | 0.35817045 |
| 126 | MAP3K13 | 0.34394669 |
| 127 | PRKG2 | 0.34258673 |
| 128 | ACVR1B | 0.34201471 |
| 129 | SGK2 | 0.33907617 |
| 130 | MAPKAPK2 | 0.33006132 |
| 131 | ALK | 0.32740759 |
| 132 | PDK1 | 0.32622471 |
| 133 | PRKCG | 0.32325587 |
| 134 | EGFR | 0.32181575 |
| 135 | IKBKB | 0.31862622 |
| 136 | ZAP70 | 0.31681586 |
| 137 | PTK2 | 0.31215696 |
| 138 | BTK | 0.30507496 |
| 139 | PBK | 0.29973518 |
| 140 | BLK | 0.29792369 |
| 141 | IRAK1 | 0.29008809 |
| 142 | ABL1 | 0.27527591 |
| 143 | JAK3 | 0.27268569 |
| 144 | CSNK1G3 | 0.27259192 |
| 145 | MTOR | 0.26891565 |
| 146 | NUAK1 | 0.26079323 |
| 147 | RET | 0.24617153 |
| 148 | MAP2K1 | 0.24500603 |
| 149 | CSNK1G2 | 0.23994504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55260682 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53335185 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.36242974 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33923493 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.18358036 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.16121177 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02563582 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79782331 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66369011 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64022135 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61323180 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.60134121 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58479303 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47188662 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.38493268 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.34283475 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33834668 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28310628 |
| 19 | Malaria_Homo sapiens_hsa05144 | 2.22497916 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15120656 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11563349 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.09598709 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06097729 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03811697 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 2.02423584 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.98609663 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98585091 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95250351 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94932489 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94868452 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94060089 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93280805 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89047723 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88715907 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86534738 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85956402 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85574447 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.84503087 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84035030 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76987608 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74885621 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.74133554 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71977127 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.71663675 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71150460 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70248189 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.67229302 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64963676 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63551754 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59722739 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55357720 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54655293 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53720481 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53667322 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50297466 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49416775 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48847074 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47017311 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45852170 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.41061297 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40803595 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40687549 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39526151 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37318039 |
| 65 | * Bile secretion_Homo sapiens_hsa04976 | 1.34853038 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34342433 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 1.32495257 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32079961 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31203579 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28655549 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28538297 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26736983 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25644804 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25487053 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 1.24439027 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23000018 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21542876 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21189398 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20471789 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 1.19157664 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17009809 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15911528 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13296703 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11737495 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11293165 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08909202 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04316568 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02857183 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02598445 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 1.02454258 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00122576 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00101435 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.98171548 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96724792 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96425117 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.96197174 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94950412 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94464162 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94373907 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93334123 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92019106 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89816348 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.89666557 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89515045 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.87747084 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84519087 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81983625 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81966543 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81625133 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.80851011 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77380793 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76232409 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.75574749 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72809403 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69448442 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69363911 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68277965 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67716554 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66337024 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63429957 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61029935 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60508455 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57136955 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56970880 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.54701141 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54588170 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52440399 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52280329 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50419027 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50339169 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49694977 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48577030 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45289198 |
| 134 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44696719 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41510365 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40483633 |
| 137 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37813458 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36665052 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.35014454 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33667063 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33602160 |
| 142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33376764 |
| 143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33268792 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30181186 |
| 145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30000152 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.29933426 |
| 147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29380858 |
| 148 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28807793 |
| 149 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27025331 |
| 150 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26586583 |
| 151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25941914 |
| 152 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25902137 |
| 153 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25888608 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22734722 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22720277 |
| 156 | Insulin resistance_Homo sapiens_hsa04931 | 0.20779973 |
| 157 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16039238 |
| 158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05927341 |
| 159 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01422774 |
| 160 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2424167 |
| 161 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2353910 |
| 162 | Legionellosis_Homo sapiens_hsa05134 | -0.2346086 |
| 163 | Pertussis_Homo sapiens_hsa05133 | -0.2119570 |
| 164 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2004031 |
| 165 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1990875 |
| 166 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1968428 |
| 167 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1910046 |
| 168 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1838322 |
| 169 | Hepatitis C_Homo sapiens_hsa05160 | -0.1639965 |
| 170 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1587553 |
| 171 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1558807 |
| 172 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1490072 |
| 173 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1410072 |
| 174 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1329805 |
| 175 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1278481 |
| 176 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0856676 |
| 177 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0716424 |
| 178 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0647783 |
| 179 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0063450 |
| 180 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0008323 |

